Capital Fund Management S.A. Esperion Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$31.18 - $52.71 $985,194 - $1.67 Million
-31,597 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$30.04 - $51.31 $949,173 - $1.62 Million
31,597 New
31,597 $1.62 Million
Q1 2020

May 13, 2020
SELL
$27.44 - $73.84 $281,260 - $756,860
-10,250 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$35.4 - $59.82 $362,850 - $613,155
10,250 New
10,250 $611,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $171M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email